Sarah Pickle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sarah Pickle has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Justine Wu
Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
4 shared publications- Shanna Duffy Stryker
Department of Family and Community Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
3 shared publications - Jules Madzia
University of Cincinnati College of Medicine, Cincinnati, USA
2 shared publications - Kelly Cleland
American Society for Emergency Contraception
2 shared publications Megan McNamara
Department of Internal Medicine at the Louis Stokes Department of Veterans Affairs Medical Center Hospital of Case Western Reserve University, Cleveland, OH, USA
2 shared publications- Pelin Batur
Obstetrics and Gynecology Institute, Cleveland Clinic, Cleveland, OH, United States
2 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (10) , 163
Training imaging professionals on transgender-inclusive breast cancer screening practices
Purpose: Transgender/gender diverse (TGD) people are underscreened for breast cancer. A barrier to screening is anticipated discrimination during screening encounters. This pilot study evaluates a training session for breast imaging professionals (clinical support specialists, technologists, and radiologists) on LGBTQIA+-inclusive breast cancer screening visits. Methods: Training topics included terminology, an overview of the guidelines, principles of trauma-informed care, and strategies for creating a welcoming and inclusive environment. Pre- and post-surveys gathered participants’ demographic information, frequency of LGBTQIA+ patient interactions, and previous exposure to LGBTQIA+ training and assessed changes in knowledge, self-reported knowledge, and attitudes toward gender diversity. Results: In pre-surveys, participants reported frequent interactions with LGBTQIA+ patients and little previous training. A 45-min didactic training that included storytelling of relevant experiences resulted in a significant increase in participants’ self-reported knowledge of LGBTQIA+ terminology with a large effect size. After training, participants correctly answered more directly assessed knowledge questions (small effect size), with a trend toward attitudes more accepting of gender diversity (medium effect size), but neither reached statistical significance. Conclusion: Continued efforts to implement and evaluate inclusive education for the entire clinical team are essential to enabling more inclusive and welcoming clinical encounters that will reduce the disparities in breast cancer screening for TGD populations.
- 18 September 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (10) , 163
Open AccessTraining imaging professionals on transgender-inclusive breast cancer screening practices
Purpose: Transgender/gender diverse (TGD) people are underscreened for breast cancer. A barrier to screening is anticipated discrimination during screening encounters. This pilot study evaluates a training session for breast imaging professionals (clinical support specialists, technologists, and radiologists) on LGBTQIA+-inclusive breast cancer screening visits. Methods: Training topics included terminology, an overview of the guidelines, principles of trauma-informed care, and strategies for creating a welcoming and inclusive environment. Pre- and post-surveys gathered participants’ demographic information, frequency of LGBTQIA+ patient interactions, and previous exposure to LGBTQIA+ training and assessed changes in knowledge, self-reported knowledge, and attitudes toward gender diversity. Results: In pre-surveys, participants reported frequent interactions with LGBTQIA+ patients and little previous training. A 45-min didactic training that included storytelling of relevant experiences resulted in a significant increase in participants’ self-reported knowledge of LGBTQIA+ terminology with a large effect size. After training, participants correctly answered more directly assessed knowledge questions (small effect size), with a trend toward attitudes more accepting of gender diversity (medium effect size), but neither reached statistical significance. Conclusion: Continued efforts to implement and evaluate inclusive education for the entire clinical team are essential to enabling more inclusive and welcoming clinical encounters that will reduce the disparities in breast cancer screening for TGD populations.
- 3 June 2024
- Published by American Speech Language Hearing Association in Perspectives of the Asha Special Interest Groups
- Vol. 9 (3) , 490-511
Insurance Coverage for Gender-Affirming Voice and Communication Services: An In-Depth Analysis in a Midwestern U.S. State
Purpose:The aim of this study was to explore the gap between the need for gender-affirming voice and communication services (GAVCS) and insurance coverage within one state.Method:An electronic, cro...
- 3 June 2024
- Published by American Speech Language Hearing Association in Perspectives of the Asha Special Interest Groups
- Vol. 9 (3) , 490-511
Insurance Coverage for Gender-Affirming Voice and Communication Services: An In-Depth Analysis in a Midwestern U.S. State
Purpose:The aim of this study was to explore the gap between the need for gender-affirming voice and communication services (GAVCS) and insurance coverage within one state.Method:An electronic, cro...
- 18 November 2019
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 21 (1) , 79-88
Considerations on medical training for gender-affirming care: Motivations and perspectives
Background: Many transgender individuals lack access to needed medical care, partially due to a lack of providers with experience in gender-affirming healthcare. Aims: The purpose of this study was to identify professional motivators for medical providers seeking out training in gender-affirming care and to define which training experiences were most beneficial to their career development. By identifying experienced providers’ recommendations on which training modalities are most relevant to their practice, we aim to suggest future directions for medical education initiatives to effectively expand the transgender care workforce. Methods: A voluntary cross-sectional electronic survey was distributed through professional listservs and publicly-available referral lists to interdisciplinary providers who self-identified as having experience in providing care to transgender individuals. Results: One hundred and fifty-three (n = 153) physicians, physician assistants, or advance-practice nurses responded to the survey. The majority (96.7%) were located in the United States, representing 37 states. The two most common motivators for seeking out training in gender-affirming care were filling a need in the community (73.0%) and/or having met a transgender-identified person in a clinical setting who requested care (63.8%). While many providers gained skills independently (57.3%), the two most commonly-available training opportunities were professional conferences (57.3%) and mentorship (41.3%). Respondents were most likely to recommend that others in their field be trained via structured clinical experience (e.g., a rotation or longitudinal exposure during training), rather than additional didactic training. Discussion: This study identifies key high-yield training methodologies which could improve access to quality gender-affirming healthcare. Through integration of structured clinical experiences during training, direct clinical mentorship, and professional development at conferences on gender-affirming care, the workforce of welcoming and prepared healthcare providers for transgender patients will increase. This will lead to a tremendous improvement on access to gender-affirming care in our communities.
- 18 November 2019
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 21 (1) , 79-88
Considerations on medical training for gender-affirming care: Motivations and perspectives
Background: Many transgender individuals lack access to needed medical care, partially due to a lack of providers with experience in gender-affirming healthcare. Aims: The purpose of this study was to identify professional motivators for medical providers seeking out training in gender-affirming care and to define which training experiences were most beneficial to their career development. By identifying experienced providers’ recommendations on which training modalities are most relevant to their practice, we aim to suggest future directions for medical education initiatives to effectively expand the transgender care workforce. Methods: A voluntary cross-sectional electronic survey was distributed through professional listservs and publicly-available referral lists to interdisciplinary providers who self-identified as having experience in providing care to transgender individuals. Results: One hundred and fifty-three (n = 153) physicians, physician assistants, or advance-practice nurses responded to the survey. The majority (96.7%) were located in the United States, representing 37 states. The two most common motivators for seeking out training in gender-affirming care were filling a need in the community (73.0%) and/or having met a transgender-identified person in a clinical setting who requested care (63.8%). While many providers gained skills independently (57.3%), the two most commonly-available training opportunities were professional conferences (57.3%) and mentorship (41.3%). Respondents were most likely to recommend that others in their field be trained via structured clinical experience (e.g., a rotation or longitudinal exposure during training), rather than additional didactic training. Discussion: This study identifies key high-yield training methodologies which could improve access to quality gender-affirming healthcare. Through integration of structured clinical experiences during training, direct clinical mentorship, and professional development at conferences on gender-affirming care, the workforce of welcoming and prepared healthcare providers for transgender patients will increase. This will lead to a tremendous improvement on access to gender-affirming care in our communities.
- 1 May 2016
- Vol. 48 (5) , 345-52
Are the Contraceptive Recommendations of Family Medicine Educators Evidence-Based? A CERA Survey.
Our study aims were to: (1) describe the scope of contraceptive methods provided by US family medicine educators and (2) assess the extent to which US family medicine educators' recommendations regarding eligibility criteria for contraceptive methods are consistent with Centers for Disease Control and Prevention (CDC) guidelines. We contributed survey items as part of the 2014 Council of Academic Family Medicine Educational Research Alliance (CERA) omnibus survey, which is distributed annually to a national cohort of US family medicine educators. We created two summary scales, comprised of clinical scenarios, to assess the extent to which provider recommendations regarding eligibility criteria for oral contraceptive pills (OCPs, six scenarios) and the intrauterine device (IUD, eight scenarios) were consistent with CDC guidelines. Among the 1,054 respondents (33% response rate), 98% prescribe OCPs and 66% insert IUDs. The OCP scale mean was 4.6 ± SD 1.6 (range 0-6), and the IUD scale mean was 4.8 SD ± 2.3 (range 0-8). These scores reflect that 23% of providers' OCP recommendations and 40% of their IUD recommendations were inconsistent with CDC guidelines. The contraceptive recommendations of this cohort of family medicine educators only partially reflected evidence-based guidelines. More misconceptions were noted regarding eligibility criteria for the IUD than for OCPs. To avoid denying safe and effective contraception to otherwise appropriate candidates and putting women at risk of unintended pregnancy, evidence-based contraceptive recommendations must be improved among family medicine educators.
- 1 May 2016
- Vol. 48 (5) , 345-52
Are the Contraceptive Recommendations of Family Medicine Educators Evidence-Based? A CERA Survey.
Our study aims were to: (1) describe the scope of contraceptive methods provided by US family medicine educators and (2) assess the extent to which US family medicine educators' recommendations regarding eligibility criteria for contraceptive methods are consistent with Centers for Disease Control and Prevention (CDC) guidelines. We contributed survey items as part of the 2014 Council of Academic Family Medicine Educational Research Alliance (CERA) omnibus survey, which is distributed annually to a national cohort of US family medicine educators. We created two summary scales, comprised of clinical scenarios, to assess the extent to which provider recommendations regarding eligibility criteria for oral contraceptive pills (OCPs, six scenarios) and the intrauterine device (IUD, eight scenarios) were consistent with CDC guidelines. Among the 1,054 respondents (33% response rate), 98% prescribe OCPs and 66% insert IUDs. The OCP scale mean was 4.6 ± SD 1.6 (range 0-6), and the IUD scale mean was 4.8 SD ± 2.3 (range 0-8). These scores reflect that 23% of providers' OCP recommendations and 40% of their IUD recommendations were inconsistent with CDC guidelines. The contraceptive recommendations of this cohort of family medicine educators only partially reflected evidence-based guidelines. More misconceptions were noted regarding eligibility criteria for the IUD than for OCPs. To avoid denying safe and effective contraception to otherwise appropriate candidates and putting women at risk of unintended pregnancy, evidence-based contraceptive recommendations must be improved among family medicine educators.
- 1 February 2016
- Published by Elsevier in Contraception
- Vol. 93 (2) , 145-152
Emergency contraception: A multispecialty survey of clinician knowledge and practices
- 1 February 2016
- Published by Elsevier in Contraception
- Vol. 93 (2) , 145-152
Emergency contraception: A multispecialty survey of clinician knowledge and practices
- 1 January 2016
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 71 (1) , 31-32
Emergency Contraception
- 1 January 2016
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 71 (1) , 31-32
Emergency Contraception
- 1 December 2014
- Published by Elsevier in Contraception
- Vol. 90 (6) , 621-622
Response to Mitchell D. Creinin’s letter regarding “Extended use of the intrauterine device: a literature review and recommendations for clinical practice”
- 1 December 2014
- Published by Elsevier in Contraception
- Vol. 90 (6) , 621-622
Response to Mitchell D. Creinin’s letter regarding “Extended use of the intrauterine device: a literature review and recommendations for clinical practice”
- 1 October 2014
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 69 (10) , 591-592
Extended Use of the Intrauterine Device
The intrauterine device (IUD) is the most cost-effective reversible contraceptive method and the most widely used. There are several advantages to use of the IUD beyond the manufacturer-approved time period. Widespread extended use of the IUD could have a significant public health impact by reducing rates of unintended pregnancy worldwide. Other advantages include patient convenience, prolongation of contraceptive and noncontraceptive benefits, avoidance of potential complications associated with reinsertion of another IUD, and cost savings. Extended IUD use is currently an off-label practice. The following questions were addressed in this study: What is the risk of pregnancy associated with extended use of copper and levonorgestrel intrauterine system (LNG-IUS) IUDs? What recommendations should be made to women regarding extended use of IUDs in current use worldwide? A literature search identified 12 articles (8 regarding copper IUDs and 4 regarding LNG-IUS) published between 1987 and 2009 that met criteria for inclusion. There is good evidence for parous women who are at least 25 years old at the time of IUD insertion to support extended use of the following devices: the TCu380A and the TCu220 for 12 years, the Multiload Cu-375 for 10 years, the frameless GyneFix (330 mm2) for 9 years, the LNG-IUS 52 mg (Mirena) for 7 years, and the Multiload Cu-250 for 4 years. The LNG-IUS 60-mg device also appears to be effective for pregnancy prevention up to 7 years in parous women 25 years or older. Women 35 years or older at the time of insertion of a TCu380A IUD can use the device until menopause with a negligible risk of pregnancy. No data were found supporting use of the LNG-IUS 13.5 mg (Skyla) beyond 3 years. There are few data for women younger than 25 years and/or nulliparous at the time of either copper or LNG-IUS IUD insertion. The risk of pregnancy among overweight or obese women who use LNG-IUDs is unclear. The risk of pregnancy is low among overweight or obese women who use copper IUDs. The authors suggest that clinicians counseling women on extended use of IUDs should consider patient characteristics and personal preferences, as well as country- and community-specific factors. More studies are needed regarding the risk of pregnancy with extended IUD use among nulliparous women and women younger than 25 years at the time of IUD insertion. Future studies should also investigate the potential effect of overweight and obesity on the long-term efficacy of LNG-IUS.
- 1 October 2014
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 69 (10) , 591-592
Extended Use of the Intrauterine Device
The intrauterine device (IUD) is the most cost-effective reversible contraceptive method and the most widely used. There are several advantages to use of the IUD beyond the manufacturer-approved time period. Widespread extended use of the IUD could have a significant public health impact by reducing rates of unintended pregnancy worldwide. Other advantages include patient convenience, prolongation of contraceptive and noncontraceptive benefits, avoidance of potential complications associated with reinsertion of another IUD, and cost savings. Extended IUD use is currently an off-label practice. The following questions were addressed in this study: What is the risk of pregnancy associated with extended use of copper and levonorgestrel intrauterine system (LNG-IUS) IUDs? What recommendations should be made to women regarding extended use of IUDs in current use worldwide? A literature search identified 12 articles (8 regarding copper IUDs and 4 regarding LNG-IUS) published between 1987 and 2009 that met criteria for inclusion. There is good evidence for parous women who are at least 25 years old at the time of IUD insertion to support extended use of the following devices: the TCu380A and the TCu220 for 12 years, the Multiload Cu-375 for 10 years, the frameless GyneFix (330 mm2) for 9 years, the LNG-IUS 52 mg (Mirena) for 7 years, and the Multiload Cu-250 for 4 years. The LNG-IUS 60-mg device also appears to be effective for pregnancy prevention up to 7 years in parous women 25 years or older. Women 35 years or older at the time of insertion of a TCu380A IUD can use the device until menopause with a negligible risk of pregnancy. No data were found supporting use of the LNG-IUS 13.5 mg (Skyla) beyond 3 years. There are few data for women younger than 25 years and/or nulliparous at the time of either copper or LNG-IUS IUD insertion. The risk of pregnancy among overweight or obese women who use LNG-IUDs is unclear. The risk of pregnancy is low among overweight or obese women who use copper IUDs. The authors suggest that clinicians counseling women on extended use of IUDs should consider patient characteristics and personal preferences, as well as country- and community-specific factors. More studies are needed regarding the risk of pregnancy with extended IUD use among nulliparous women and women younger than 25 years at the time of IUD insertion. Future studies should also investigate the potential effect of overweight and obesity on the long-term efficacy of LNG-IUS.